| 000 | 01854 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250515034859.0 | ||
| 264 | 0 | _c20061016 | |
| 008 | 200610s 0 0 eng d | ||
| 022 | _a1537-6591 | ||
| 024 | 7 |
_a10.1086/505870 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCornillet, A | |
| 245 | 0 | 0 |
_aComparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. _h[electronic resource] |
| 260 |
_bClinical infectious diseases : an official publication of the Infectious Diseases Society of America _cSep 2006 |
||
| 300 |
_a577-84 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Fungal _xblood |
| 650 | 0 | 4 |
_aAntifungal Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntigens, Fungal _xblood |
| 650 | 0 | 4 |
_aAspergillosis _xcomplications |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeutropenia _xcomplications |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aCamus, C | |
| 700 | 1 | _aNimubona, S | |
| 700 | 1 | _aGandemer, V | |
| 700 | 1 | _aTattevin, P | |
| 700 | 1 | _aBelleguic, C | |
| 700 | 1 | _aChevrier, S | |
| 700 | 1 | _aMeunier, C | |
| 700 | 1 | _aLebert, C | |
| 700 | 1 | _aAupée, M | |
| 700 | 1 | _aCaulet-Maugendre, S | |
| 700 | 1 | _aFaucheux, M | |
| 700 | 1 | _aLelong, B | |
| 700 | 1 | _aLeray, E | |
| 700 | 1 | _aGuiguen, C | |
| 700 | 1 | _aGangneux, J-P | |
| 773 | 0 |
_tClinical infectious diseases : an official publication of the Infectious Diseases Society of America _gvol. 43 _gno. 5 _gp. 577-84 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1086/505870 _zAvailable from publisher's website |
| 999 |
_c16474610 _d16474610 |
||